148 related articles for article (PubMed ID: 8396947)
1. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins.
Cachianes G; Ho C; Weber RF; Williams SR; Goeddel DV; Leung DW
Biotechniques; 1993 Aug; 15(2):255-9. PubMed ID: 8396947
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
[TBL] [Abstract][Full Text] [Related]
3. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
4. Efficient foreign gene expression in Epstein-Barr virus-transformed human B-cells.
Curiel TJ; Cook DR; Bogedain C; Jilg W; Harrison GS; Cotten M; Curiel DT; Wagner E
Virology; 1994 Feb; 198(2):577-85. PubMed ID: 8291240
[TBL] [Abstract][Full Text] [Related]
5. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
6. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ; Feederle R; Behrends U; Mautner J
Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP
Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
[TBL] [Abstract][Full Text] [Related]
8. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
9. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
10. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
11. Construction of Epstein-Barr virus-based expression vector containing mini-oriP.
Tanaka J; Miwa Y; Miyoshi K; Ueno A; Inoue H
Biochem Biophys Res Commun; 1999 Nov; 264(3):938-43. PubMed ID: 10544034
[TBL] [Abstract][Full Text] [Related]
12. Construction of an EBNA-producing line of well-differentiated human hepatoma cells and of appropriate Epstein-Barr virus-based shuttle vectors.
Lutfalla G; Armbruster L; Dequin S; Bertolotti R
Gene; 1989 Mar; 76(1):27-39. PubMed ID: 2545532
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
14. An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression.
Shan L; Wang L; Yin J; Zhong P; Zhong J
J Gene Med; 2006 Dec; 8(12):1400-6. PubMed ID: 17051599
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
16. Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cells.
Sia KC; Chong WK; Ho IA; Yulyana Y; Endaya B; Huynh H; Lam PY
J Gene Med; 2010 Oct; 12(10):848-58. PubMed ID: 20963807
[TBL] [Abstract][Full Text] [Related]
17. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
Wang Y; Finan JE; Middeldorp JM; Hayward SD
Virology; 1997 Sep; 236(1):18-29. PubMed ID: 9299613
[TBL] [Abstract][Full Text] [Related]
18. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
[TBL] [Abstract][Full Text] [Related]
19. The activation of lytic replication of Epstein-Barr virus by baculovirus-mediated gene transduction.
Wang L; Shan L; Yin J; Zhao M; Su D; Zhong J
Arch Virol; 2006 Oct; 151(10):2047-53. PubMed ID: 16673043
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter.
Swaminathan S
Virology; 1996 Mar; 217(2):532-41. PubMed ID: 8610445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
